Imipenem monohydrate is a beta-lactam carbapenem antibiotic derived from Streptomyces cattleya. It inhibits bacterial cell wall synthesis and exhibits broad-spectrum activity against Gram-positive and Gram-negative pathogens, making it valuable for in vitro susceptibility testing and research into bacterial resistance mechanisms.
